Enhancing study success with advanced clinical research technologies and expert solutions for Breast Cancer trials.
Breast Cancer
Trial Solutions
Effective solutions for advancing Breast Cancer research
Breast cancer affects more women worldwide than any other cancer. Despite its prevalence, studying and improving treatment is extremely complex. Oncology studies often involve multiple cohorts, tumor types, scattered sites, and expensive medications. More importantly, breast cancer patients face debilitating symptoms that can make participation in studies difficult. That's where Signant's evidence generation solutions and deep oncology experience can help.
Why Signant Health
- Capture Accurate Data & Incorporate PROMS
- Place the Patient First
- Gain Richer Insights
- Simplify the Consent Process
- Optimize Supply Management
- Digitalize the Entire Process
-
Capture Accurate Data & Incorporate PROMS
Capture Accurate Data & Incorporate PROMS
Leverage our leading digital solutions as well as extensive clinical and eCOA science expertise to capture high-quality, reliable endpoint data. And with our deep understanding of recent FDA guidance on the use of patient-reported outcomes in oncology trials, we're prepared to help you incorporate patients' perspectives in your data capture strategy. -
Place the Patient First
Place the Patient First
Our patient-focused approach is embedded in everything from the software to the eCOA instruments’ overall designs. For example, thoughtfully migrating instrument layouts to electronic formats to ensure ease of use, such as larger, well-spaced buttons compensate for treatment-related finger numbness. -
Gain Richer Insights
Gain Richer Insights
With our sensors and wearables, you can collect objective data on sleep and activity patterns, for enhanced insight into the post-treatment recovery associated with each treatment cycle. Pair with our eCOA for a continuous, real-time view of each patients’ health status. -
Simplify the Consent Process
Simplify the Consent Process
Signant SmartSignals eConsent uses engaging multimedia to convey complex information and allows patients to flag sections they have questions on. The solution also handles the multiple consents and protocol amendments common in breast cancer trials, limiting the risk of inspection findings. -
Optimize Supply Management
Optimize Supply Management
Our Signant SmartSignals RTSM solution uses proprietary algorithms to optimize drug supplies for the different, complex study designs associated with breast cancer trials, and applies randomization adaptations seamlessly. -
Digitalize the Entire Process
Digitalize the Entire Process
While all of our solutions can be used as standalone tools, they seamlessly integrate with one another to further enhance the accuracy and efficiency of your breast cancer study.
Comprehensive Breast Cancer experience
0
STUDIES
0
PATIENTS
0
COUNTRIES
0
SITES
Explore our Breast Cancer trial resources
eClinical solutions for Breast Cancer trials
Ready to learn more?
Discover how Signant can support your current or upcoming breast cancer trials.